AFX — Carl Zeiss Meditec AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual income statement for Carl Zeiss Meditec AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,647	1,903	2,089	2,066	2,228
Cost of Revenue
Gross Profit	967	1,128	1,206	1,089	1,175
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,273	1,506	1,741	1,872	2,004
Operating Profit	374	397	348	194	223
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	339	403	413	241	194
Provision for Income Taxes
Net Income After Taxes	238	296	292	180	142
Minority Interest
Net Income Before Extraordinary Items
Net Income	236	294	290	179	141
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	236	294	290	179	141
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.62	3.29	3.25	2.01	1.61
Dividends per Share